Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.
Buckley, Patrick G
Foley, Niamh H
Murphy, Derek M
London, Wendy B
McGrady, Patrick W
Higgins, Desmond G
Stallings, Raymond L
AffiliationDepartment of Cancer Genetics, Royal College of Surgeons in Ireland, Dublin, Ireland.
MeSHCell Line, Tumor
Gene Expression Regulation, Neoplastic
Nervous System Neoplasms
Nucleic Acid Hybridization
Reverse Transcriptase Polymerase Chain Reaction
Sensitivity and Specificity
Sequence Analysis, DNA
Sympathetic Nervous System
MetadataShow full item record
CitationWidespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival. 2009, 4 (11):e7850 PLoS ONE
AbstractMiRNAs regulate gene expression at a post-transcriptional level and their dysregulation can play major roles in the pathogenesis of many different forms of cancer, including neuroblastoma, an often fatal paediatric cancer originating from precursor cells of the sympathetic nervous system. We have analyzed a set of neuroblastoma (n = 145) that is broadly representative of the genetic subtypes of this disease for miRNA expression (430 loci by stem-loop RT qPCR) and for DNA copy number alterations (array CGH) to assess miRNA involvement in disease pathogenesis. The tumors were stratified and then randomly split into a training set (n = 96) and a validation set (n = 49) for data analysis. Thirty-seven miRNAs were significantly over- or under-expressed in MYCN amplified tumors relative to MYCN single copy tumors, indicating a potential role for the MYCN transcription factor in either the direct or indirect dysregulation of these loci. In addition, we also determined that there was a highly significant correlation between miRNA expression levels and DNA copy number, indicating a role for large-scale genomic imbalances in the dysregulation of miRNA expression. In order to directly assess whether miRNA expression was predictive of clinical outcome, we used the Random Forest classifier to identify miRNAs that were most significantly associated with poor overall patient survival and developed a 15 miRNA signature that was predictive of overall survival with 72.7% sensitivity and 86.5% specificity in the validation set of tumors. We conclude that there is widespread dysregulation of miRNA expression in neuroblastoma tumors caused by both over-expression of the MYCN transcription factor and by large-scale chromosomal imbalances. MiRNA expression patterns are also predicative of clinical outcome, highlighting the potential for miRNA mediated diagnostics and therapeutics.
- miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs.
- Authors: Terrile M, Bryan K, Vaughan L, Hallsworth A, Webber H, Chesler L, Stallings RL
- Issue date: 2011
- Focal DNA copy number changes in neuroblastoma target MYCN regulated genes.
- Authors: Kumps C, Fieuw A, Mestdagh P, Menten B, Lefever S, Pattyn F, De Brouwer S, Sante T, Schulte JH, Schramm A, Van Roy N, Van Maerken T, Noguera R, Combaret V, Devalck C, Westermann F, Laureys G, Eggert A, Vandesompele J, De Preter K, Speleman F
- Issue date: 2013
- Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
- Authors: Buechner J, Henriksen JR, Haug BH, Tømte E, Flaegstad T, Einvik C
- Issue date: 2011 Jan
- Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.
- Authors: Haug BH, Hald ØH, Utnes P, Roth SA, Løkke C, Flægstad T, Einvik C
- Issue date: 2015 May
- ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value.
- Authors: Vandesompele J, Edsjö A, De Preter K, Axelson H, Speleman F, Påhlman S
- Issue date: 2003 Jan 23